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ABSTRACT
pSTIING (http://pstiing.licr.org) is a new publicly
accessible web-based application and knowle-
dgebase featuring 65228 distinct molecular asso-
ciations (comprising protein–protein, protein–lipid,
protein–small molecule interactions and transcrip-
tional regulatory associations), ligand–receptor–cell
type information and signal transduction modules. It
has a particular major focus on regulatory networks
relevant to chronic inflammation, cell migration and
cancer. The web application and interface provide
graphical representations of networks allowing
users to combine and extend transcriptional regulat-
ory and signalling modules, infer molecular inter-
actions across species and explore networks via
protein domains/motifs, gene ontology annotations
and human diseases. pSTIING also supports the
direct cross-correlation of experimental results with
interaction information in the knowledgebase via
the CLADIST tool associated with pSTIING, which
currently analyses and clusters gene expression,
proteomic and phenotypic datasets. This allows the
contextual projection of co-expression patterns
onto prior network information, facilitating the iden-
tification of functional modules in physiologically
relevant systems.
INTRODUCTION
The advent of high-throughput genomic and proteomic
approaches coupled with annotation efforts has generated a
comprehensive ‘parts list’ of biomolecules encoded by the
genome, resulting in the establishment of a number of publicly
available repositories and databases, each focussing on a cer-
tain specialized aspect of biological data collection, ranging
from gene information [e.g. UniGene (1)], protein entries
[e.g. UniProt (2)] and structural domain information [e.g.
Pfam(3),InterPro(4)andCATH(5)]tomolecularinteractions
[e.g. MINT (6) and BIND (7)] and pathways [e.g. BioCarta
(www.biocarta.com) and KEGG (8)].
The extraction of meaningful information in the context of
physiological systems requires characterization of not only the
function of individual genes or proteins but also the physical
interactions and functional associations in which they parti-
cipate. To this end, recent genome-wide interactome projects
involving two-hybrid (9), co-immunoprecipitation, protein
chip analyses (10), afﬁnity puriﬁcation (11,12) and mass spec-
trometry (13) have produced a wealth of protein–protein
interaction data.
Cellular and physiological processes are complex systems
(14) modulated by signals from the extracellular environment
and coordinated by the interplay of intracellular regulatory
networks assembled into functional modules (15) and path-
ways. Regulatory networks comprise molecular (protein–
protein, protein–lipid, protein–small molecule) interactions
and transcriptional regulatory associations between trans-
cription factors and the protein products of genes they
trans-activate.
In order to understandthese processes as interconnected and
interdependent systems, there is a need to derive new associ-
ations from not only molecular interaction data but also integ-
rating this with transcriptional regulatory associations, signal
transduction modules and other information with corrobora-
ting evidence from multiple diverse sources, which often
entails bringing together heterogeneous data. This is necessary
to facilitate effective cross-correlation with expression and
functional analyses in physiologically relevant investigations.
In light of this, we developed Protein, Signalling, Trans-
criptional Interactions and Inﬂammation Networks Gateway
(pSTIING), a publicly accessible knowledgebase and web
application to facilitate an integrative ‘systems’ approach
towards understanding inﬂammation, cell migration and
cancer. The knowledgebase integrates protein–protein,
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actions, receptor–cell type associations, disease information
and transcriptional associations with signal transduction mod-
ules. Experimental data from gene expression or proteomic
analyses can also be directly cross-correlated with network
information in pSTIING via CLADIST, a clustering and
data analysis tool associated with pSTIING. pSTIING-
CLADIST is accessible at http://pstiing.licr.org.
DATA SOURCES AND DATABASE ACCESS
pSTIING contains data manually curated from the literature
and publicly available data derived from multiple sources as
listed under six broad categories in Table 1. As pSTIING is
growing rapidly, we expect the numbers and data sources
listed in Table 1 to change very quickly. Because our current
strategy for building pSTIING is to adopt a selective approach
rather than taking the ‘all-inclusive’ route towards data integ-
ration, we highlight in Table 1 the various subsets of data that
were included or not incorporated into pSTIING as it stands
currently.
For example, we incorporated 2200 experimentally veriﬁed
transcriptional associations from TRED that have been ranked
highly for promoter and binding quality (16). Lower ranked
entries such as from computational predictions or those sup-
ported by indirect or unreliable evidence are not incorporated.
To facilitate efﬁcient storage and retrieval of interaction
data, we constructed a relational database in an SQL (Oracle)
server. The model underlying the database structure at its core
consists of modules, interactions and interacting entities.
A module (e.g. IL6 signalling module or STAT3 trans-
criptional module) is a biologically or functionally relevant
grouping of interactions or associations. For example, we are
building a curated collection of signalling modules by not only
providing curated information at the pathway level [as with
BioCarta, KEGG (8), STKE (www.stke.org) and AfCS (www.
signaling-gateway.org)] but also focussing on individual
interactions and associations within signalling modules. The
assembly of interactions into functionally relevant signalling
modules is an on-going effort involving manual literature
curation and also using BioCarta, KEGG, STKE and AfCS
as general reference resources.
Interactions between interacting entities can be direct
(e.g. physical, stimulatory or inhibitory) or indirect (e.g. tran-
scriptional associations). Each interaction has a source (e.g.
MINT, HPRD or our in-house curated set) and is supported by
experiments which have Pubmed ID links. Currently, most
interactions in pSTIING are binary but can also involve more
than two interacting entities, which can be any small molecule
(e.g. Ca
2+) or biomolecules (including proteins and lipids).
Small molecules and lipids are linked to KEGG compound
identiﬁers. Proteins are linked to protein-related information
Table 1. Data sources
Categories Data sources Data incorporated into pSTIING
General protein
and gene-related
information
UniProt (2) 180823 entries from key organisms
a and S.pombe.
UniRef90 (2) 111850 entries from key organisms
a and S.pombe.
UniRef50 (2) 74650 entries from key organisms
a and S.pombe.
InterPro (4) 7309 entries.
Entrez Gene (30) 1280648 entries.
Genew/HGND (31) 23914 entries.
UniGene (1) 53256 clusters.
GOA (18) 19141 entries.
Orthologous groups KOG/COG (19) 4852 orthologous groups involving 26477 proteins from H.sapiens, M.musculus, D.melanogaster,
C.elegans. Entries lacking SwissProt/TrEMBL identifiers are excluded.
Human disease OMIM (20) 3466 human disease entries.
Molecular interactions MINT (6) 47403 interactions involving 17774 interacting entities from key organisms
a.
BIND (7) 11568 interactions involving 6161 interacting proteins from key organisms
a. Self-interactors and entries
lacking SwissProt/TrEMBL identifiers are excluded. Currently, non-protein–protein interactions are
not included. Protein-small molecule interactions from BIND will be included soon.
Reactome (32) 11452interactions(‘reaction’type)involving520interactingentitiesfromH.sapiens.Self-interactorsand
indirect interactions excluded. Macromolecular complexes from Reactome will be included soon.
HPRD (33) 7011 interactions involving 5516 interacting entities from H.sapiens. Self-interactors or entries lacking
SwissProt/TrEMBLidentifiersandinteractorsambiguouslyclassifiedas‘mammalian’ratherthanfrom
a clearly defined species are excluded. Macromolecular complexes from HPRD will be included soon.
In-house curated set 709 protein–protein [including ligand–receptor (34,35)], protein–small molecule, protein–lipid interac-
tions manually curated from the literature.
MIPS (36) 461 interactions from H.sapiens, R.norvegicus, M.musculus. Self-interactors lacking SwissProt/TrEMBL
identifiers and interactions with low-confidence MIPS score are excluded.
Transcriptional and
Signalling modules
and pathways
In-house curated set Currently 11 signalling modules (H.sapiens) involving 561 interactions manually curated from the
literature. Other reference sources: BioCarta, KEGG, STKE, AfCS.
TRED (16) 2200 experimentally verified transcriptional associations (H.sapiens) were incorporated, of which 568
have been placed into transcriptional modules in pSTIING. Associations determined by indirect
evidence or prediction methods are excluded.
KEGG (8) 21 signalling pathways involving 1441 proteins (H.sapiens).
BioCarta 241 signalling pathways involving 1165 proteins (H.sapiens) from BioCarta (www.biocarta.com).
Receptor, CD marker
and Cell type
information
In-house curated set
HCDM/HLDA8
797CDmarker/receptor-celltypeassociationsmanuallycuratedfromtheliteratureandPathologyOutlines
(www.pathologyoutlines.com).
358 CD marker entries from HCDM (www.hlda8.org).
aKey organisms: H.sapiens, R.norvegicus, M.musculus, D.melanogaster, C.elegans and S.cerevisiae.
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(4) accession], protein structure [via PDB (17) ID], gene
ontology (GO) [via GOA (18) ID], orthology [via KOG
(19) ID], human disease [via OMIM (20) ID] and taxonomy
classiﬁcation [via Taxonomy (1) ID]. Organisms represented
in pSTIING include Homo sapiens (Taxonomy ID: 9606),
Rattus norvegicus (10116), Mus musculus (10090), Droso-
phila melanogaster (7227), Caenorhabditis elegans (6239)
and Saccharomyces cerevisiae (4932).
The pSTIING web interface provides a number of starting
points from which to navigate the database (Supplementary
Data 1). Users may perform single or multiple (batch) searches
using protein or gene name, synonyms or identiﬁers (such
as SwissProt or TrEMBL accessions) which retrieve informa-
tion about interacting entities, interactions, transcriptional
associations and pathway modules, with supporting experi-
mental evidence and extensive cross-references to external
databases (Supplementary Data 2).Users canalsoquery across
species, via GO annotations, InterPro domains, motifs, human
diseases or using datasets from gene expression or proteomic
experiments.
VISUALIZING INTERACTIONS,
TRANSCRIPTIONAL ASSOCIATIONS
AND EXTENDING PATHWAYS
pSTIING dynamically generates graphical representations of
interaction networks and displays maps in both compressed
and scalable vector graphics (SVG) formats. With a suitable
SVG viewer plug-in for browsers such as Corel SVG or Adobe
SVG viewers, users will be able to zoom in and out, or move
(pan) a network map around within the viewing screen. Nodes
representinteractingcomponents(e.g. proteins,macromolecu-
lar assemblies, lipids or small molecules) and edges represent
interaction or transcriptional regulatory relationships between
components.
In signalling modules, these edges may be directed, denot-
ing stimulatory or inhibitory interactions, or undirected, rep-
resenting molecular interactions that are neither stimulatory
nor inhibitory, or where their stimulatory/inhibitory status is
not known. In pSTIING, the representation of a transcriptional
association is abstracted to indicate the relationship between
two proteins, one of which is a transcription factor that
trans-activates the expression of the gene encoding the other
protein. Such associations are represented by dashed edges.
Depending on the respective display mode selected, edges are
colour-coded to highlight a speciﬁc module or a cellular com-
partment, within which an interaction occurs, or to indicate
the number of documented experimental types supporting an
interaction.
Interaction maps can also be progressively expanded out-
wards to display the next interaction neighbourhood or sub-
sequent levels beyond, thus, making it possible to ‘grow’
networks or extend signalling pathway modules in a desired
direction. For example, by selecting mitogen-activated protein
kinase kinase 3 (MAP2K3) and MAP2K6 from a list of
interactors in the Toll-like receptor (TLR) signalling module,
the network can be extended to display subsequent inter-
action levels with MAP2K3 and MAP2K6 at the centre of
the interaction network (Figure 1A). By clicking the ‘Display
Network (‘Backbone’)’ button, it is possible to display only
the query nodes and their immediate interaction partners
that link query nodes together. This feature is useful for
simplifying complex network maps.
LINKING TRANSCRIPTIONAL ASSOCIATIONS
TO SIGNALLING MODULES
Regulatory networks comprise both transcriptional regulatory
modules and molecular interaction cascades organized within
signal transduction modules. Therefore, the incorporation of
transcriptional regulatory associations with molecular inter-
action information is necessary to connect seemingly distinct
signalling modules into functional regulatory systems. In
pSTIING, multiple signalling and transcriptional regulatory
modules canbedisplayedincombination,facilitating the iden-
tiﬁcation of important ‘cross-talk’ points (or ‘hubs’) between
modules.
As an example, Figure 1A illustrates this cross-module con-
nectivity between TLR, interferon (IFN) a/b, IFN-g and che-
mokine signalling modules participating in an inﬂammatory
response against gram-negative bacteria infection. Bacterial
lipopolysaccharide interacts with TLR4 and triggers a cascade
of signalling events in the TLR pathway, leading to activation
of the transcription factor, IRF3. IRF3 binds to its cis element
in the promoter of genes encoding type I IFNs (IFN-a and
IFN-b) and C–C chemokine, CCL5, inducing their expression.
The type I IFN signalling cascade induces the production and
secretion of type II IFNs (IFN-g) via the transcription factor
STAT1. IFN-g triggers a second wave of STAT1 activation
which reinforces the ﬁrst in a positive feed-back loop. Also,
CCL5 promiscuously activates three G-protein-coupled
receptors CCR1, CCR3 and CCR5 which are expressed on
a variety of immunologically relevant cell types, thus trans-
mitting extracellular cues to appropriate effector cells as rep-
resented in pSTIING (Figure 1B and Supplementary Data 3).
Clicking on a ‘cell type’ node retrieves information about
cell surface (CD or Cluster of Differentiation) markers that
phenotypically identify this cell type.
PROJECTING AND MAPPING INTERACTIONS
ACROSS SPECIES
The integration of homology information with molecular
interaction data allows us to project and map interactions
Figure 1. Graphical maps generated in pSTIING showing (A) cross-connectivity between four intracellular signalling modules (TLR, IFN-a/b, IFN-g and
Chemokine) and two transcriptional regulatory modules (STAT1 and IRF3). Interactions are represented by solid edges while transcriptional associations by
dashed lines. Each component node (e.g. IRAK1) is linked to more extensive information about the component (including interaction partners, InterPro domains,
GO, homologous proteins and cross-links to externaldatabases). Clicking on an interaction node provides interaction details and experimental evidence supporting
that interaction. Pathways can be extended in a desired direction by displaying subsequent interaction neighbourhood levels centered on interactors selected by
users (e.g. mitogen-activated kinase kinases, MAP2K3 and MAP2K6). (B) Representation of ligand–receptor–cell type associations. The ligand CC-chemokine
CCL5 activates a subset of leukocytes and lymphocytes by binding to chemokinereceptors CCR1, CCR3 and CCR5 expressed on these cell types. Each ligand and
receptor node is linked to detailed information about the respective protein and their interaction partners. Information about each cell type, its related or parental
cell types and the cell surface markers (CD antigens) that phenotypically identifies the cell type can be accessed by clicking on the cell type node.
D530 Nucleic Acids Research, 2006, Vol. 34, Database issueNucleic Acids Research, 2006, Vol. 34, Database issue D531known for a protein onto homologous (and where possible,
orthologous) proteins across species in which the interaction
information is not as extensive or not available (Figure 2A).
Our aim is to obtain as much additional insights as it is poss-
ible about the human interactome by inferring from model
organisms.
pSTIING provides three approaches whereby users can
choose to query interaction information across species. The
ﬁrst uses orthology groupings from Clusters of Orthologous
Groups (COG/KOG) (19). The second approach involves
UniRef 50/90 (2) clusters of proteins with at least 50 or
90% identity, respectively. The third employs a reciprocal
best hit approach to map protein interaction information
(where available) in model organisms (rat, mouse, ﬂy,
worm and yeast) onto human orthologues. Sequence similarity
(BLASTP) searches against human proteins were performed
for each model organism protein, and reciprocal searches
carried out for each top BLAST hit. Each reciprocal best
match is selected as a potential orthologue and its interactions
displayed graphically. Also shown is the extent of sequence
similarity (percent identity, BLAST score and E-value)
between orthologous proteins, which provides an indication
of the level of conﬁdence associated with the inferred or pro-
jected interactions (Figure 2A and Supplementary Data 4).
INTERACTION NETWORKS VIA ONTOLOGY,
MOTIFS AND INTERPRO DOMAINS
GOannotation(18)providesawell-structuredsetofcontrolled
common vocabularies to describe the molecular function of
gene products and proteins, the biological processes with
which they are associated and the cellular compartments in
which they are located. The inclusion of GO annotation terms
and category identiﬁers into pSTIING facilitates the construc-
tion of interaction networks associated with a chosen GO
annotation.
For example, a search using a phrase for a biological
process like ‘regulation of apoptosis’, returns several possible
matching terms, including ‘positive regulation of apoptosis’
(GO:0043065) and ‘negative regulation of apoptosis’
(GO:0043066) from which users could reﬁne and select the
appropriate term (Supplementary Data 5). There are several
display options available. The ‘protein’ option generates
graphical maps of interactions between proteins associated
with the selected GO term. As for ‘UniRef 50/90’ and
‘COG/KOG’ options, the GO search is combined with cross-
species homology information, producing graphical rep-
resentations of interactions between UniRef or COG/KOG
clusters, respectively.
It is also possible to explore interaction networks of
proteins with similar InterPro domains or motifs. pSTIING
supports searches by InterPro accession, InterPro name or
regular expression specifying conserved motifs (Supple-
mentary Data 6).
HUMAN DISEASE AND INTERACTION
NETWORKS
Many human diseases including inﬂammatory and auto-
immune disorders (21–23), atherosclerosis (24) and cancers
(25,26) have complex aetiologies associated with a variety
of environmental cues feeding into a number of interaction
networks or modules leading to aberrant perturbations at the
‘systems’ level.
A list of diseases was selected from the OMIM (20) morbid
map initiative, and the information about proteins whose
de-regulation or mutation have association or causal impli-
cation in disease was integrated with interaction information
in pSTIING. For example, searching ‘colorectal cancer’ or
‘breast cancer’ will return information and OMIM links
about the disorder (such as clinical synopses) and associated
chromosomal loci. pSTIING will graphically represent
interaction networks of proteins implicated in the disease
(Figure 2B).
LINKING GENE EXPRESSION AND PROTEOMIC
EXPERIMENTS TO INTERACTION AND
REGULATORY NETWORKS
Filtered and normalized datasets from gene expression
[including microarrays and massively parallel signature
sequencing (MPSS)] and proteomic experiments can be
imported into pSTIING via CLADIST, a clustering tool asso-
ciated with pSTIING. pSTIING-CLADIST features various
clustering algorithms including hierarchical clustering,
k-means and self-organizing maps (SOM) from which users
could select the clusters of co-regulated genes or proteins and
directly cross-correlate these with molecular interaction and
transcriptional information in pSTIING.
This feature allows the contextual projection of co-
expression patterns onto prior network information, facilitat-
ing the assembly of protein interaction and transcriptional
regulatory networks into functional modules. For example,
Figure 2C shows the identiﬁcation of a set of genes that
are co-ordinately expressed across tumour and non-tumour
cells. When linked to information in pSTIING, preliminary
data reveals an underlying network of protein–protein inter-
actions and transcriptional regulatory associations, suggest-
ing their involvement in the same functional module or
programme within the context of the physiological state
examined.
Figure 2. (A) The identification of potential orthologues using human-model organism reciprocal similarity (BLASTP) searches allows additional interaction
information to be projected from model organism proteins onto orthologous proteins in human. The sequence similarity between orthologous proteins (percent
identity, BLAST score and E-value) for each query protein is displayed alongside their interaction information and when consolidated across species, these
interactions are mapped onto human proteins. As a comparison, the corresponding interaction map without orthology mapping is shown. (B) pSTIING supports
querying by human disease, facilitating the exploration of interaction and transcriptional regulatory associations between proteins implicated in disease (e.g. breast
cancer). (C) Linking of expression analysis to molecular interaction networks (represented by solid edges) and transcriptional regulatory modules (dashed lines)
using pSTIING-CLADIST. The CLADIST tool associated with pSTIING provides various clustering algorithms including SOM, which was used to identify a
cluster of co-ordinately expressed genes (represented by nodes with red labels) from MPSS expression analyses of tumour and non-tumour samples. These were
then cross-correlated directly with interaction and transcriptional information in pSTIING to detect any underlying physical or functional associations.
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Building on molecular interaction data provided by publicly
available databases [including MINT, MIPS, BIND, IntAct
(27), STRING (28) and DIP (29)], pSTIING offers a unique
resource in that it integrates transcriptional regulatory associ-
ations with molecular interaction data and signalling modules,
allowing researchers and students to explore and extend regu-
latory networks using experimental data or by searching on
protein domains/motifs, GO annotations, human diseases and
orthologous proteins across species.
We will continue to assemble molecular interaction and
transcriptional regulatory networks into functional pathways,
particularly those that underpin inﬂammatory processes,
cell migration and tumourigenesis. Hence, we welcome and
encourage contributions from investigators towards this open
resource via the pSTIING website.
We will also expand the knowledgebase to include quant-
itative data from directed expression and functional studies to
examine the temporo-spatial dynamics of regulatory networks
as determined by cell type, the state of a cell, its micro-
environment and extracellular cues, in the context of a speciﬁc
physiological process orpathologicalcondition.Thisiscritical
for the development of realistic and predictive quantitative
models of biological systems, which we envisage pSTIING
to facilitate in the future.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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